111 related articles for article (PubMed ID: 12458038)
1. Characterization of neurotransmitters and dopamine attenuation of inducible nitric oxide synthase in glioma cells.
Mazzio E; Becker A; Soliman KF
J Neuroimmunol; 2002 Oct; 131(1-2):70-82. PubMed ID: 12458038
[TBL] [Abstract][Full Text] [Related]
2. Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity.
Chen J; Wersinger C; Sidhu A
J Biol Chem; 2003 Jul; 278(30):28089-100. PubMed ID: 12738794
[TBL] [Abstract][Full Text] [Related]
3. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes.
Harbrecht BG; Taylor BS; Xu Z; Ramalakshmi S; Ganster RW; Geller DA
J Surg Res; 2001 Aug; 99(2):258-64. PubMed ID: 11469895
[TBL] [Abstract][Full Text] [Related]
4. Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells.
Soliman MK; Mazzio E; Soliman KF
Life Sci; 2002 Nov; 72(2):185-98. PubMed ID: 12417252
[TBL] [Abstract][Full Text] [Related]
5. Nepalolide A inhibits the expression of inducible nitric oxide synthase by modulating the degradation of IkappaB-alpha and IkappaB-beta in C6 glioma cells and rat primary astrocytes.
Wang CN; Shiao YJ; Lin YL; Chen CF
Br J Pharmacol; 1999 Sep; 128(2):345-56. PubMed ID: 10510444
[TBL] [Abstract][Full Text] [Related]
6. Forskolin inhibits expression of inducible nitric oxide synthase mRNA via inhibiting the mitogen activated protein kinase in C6 cells.
Won JS; Lee JK; Suh HW
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):1-10. PubMed ID: 11311970
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and inducible nitric oxide synthase have no effect on monoamine oxidase activity in glioma cells.
Mazzio E; Becker A; Soliman KF
Biochem Pharmacol; 2003 May; 65(10):1719-27. PubMed ID: 12754108
[TBL] [Abstract][Full Text] [Related]
9. Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells.
Lee JK; Won JS; Singh AK; Singh I
Neuropharmacology; 2005 Jan; 48(1):151-60. PubMed ID: 15617735
[TBL] [Abstract][Full Text] [Related]
10. Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes.
Ziolo MT; Katoh H; Bers DM
Circulation; 2001 Dec; 104(24):2961-6. PubMed ID: 11739313
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
Lee NP; Cheng CY
Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
[TBL] [Abstract][Full Text] [Related]
12. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
13. Dopamine stimulation of cAMP production in cultured opossum kidney cells.
Cheng L; Precht P; Frank D; Liang CT
Am J Physiol; 1990 Apr; 258(4 Pt 2):F877-82. PubMed ID: 1691897
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase.
Stefano GB; Salzet M; Magazine HI; Bilfinger TV
J Cardiovasc Pharmacol; 1998 Jun; 31(6):813-20. PubMed ID: 9641464
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.
Correia-de-Sá P; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):514-22. PubMed ID: 7870191
[TBL] [Abstract][Full Text] [Related]
16. Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability.
Won JS; Im YB; Singh AK; Singh I
Free Radic Biol Med; 2004 Dec; 37(11):1834-44. PubMed ID: 15528042
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors.
Minghetti L; Nicolini A; Polazzi E; Créminon C; Maclouf J; Levi G
Glia; 1997 Feb; 19(2):152-60. PubMed ID: 9034831
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells.
Birder LA; Nealen ML; Kiss S; de Groat WC; Caterina MJ; Wang E; Apodaca G; Kanai AJ
J Neurosci; 2002 Sep; 22(18):8063-70. PubMed ID: 12223560
[TBL] [Abstract][Full Text] [Related]
19. Effect of cAMP on inducible nitric oxide synthase gene expression: its dual and cell-specific functions.
Okado-Matsumoto A; Matsumoto A; Fujii J; Taniguchi N
Antioxid Redox Signal; 2000; 2(4):631-42. PubMed ID: 11213468
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
